Tenax Therapeutics (NASDAQ:TENX) Earns Sell Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Free Report) in a research note released on Wednesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Several other research analysts have also commented on TENX. Leerink Partners set a $20.00 target price on Tenax Therapeutics in a research report […]
StockNews.com started coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Free Report) in a research note released on Wednesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Several other research analysts have also commented on TENX. Leerink Partners set a $20.00 target price on Tenax Therapeutics in a research report […]
